A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1

Histone deacetylase (HDAC) inhibitors are considered novel agents for cancer chemotherapy. We previously investigated MHY219, a new HDAC inhibitor, and its potent anticancer activity in human prostate cancer cells. In the present study, we evaluated MHY219 molecular mechanisms involved in the regula...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomol Ther (Seoul)
Main Authors: De, Umasankar, Kundu, Soma, Patra, Nabanita, Ahn, Mee Young, Ahn, Ji Hae, Son, Ji Yeon, Yoon, Jung Hyun, Moon, Hyung Ryoung, Lee, Byung Mu, Kim, Hyung Sik
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Society of Applied Pharmacology 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4556203/
https://ncbi.nlm.nih.gov/pubmed/26336583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2015.026
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares